Mortenson D, Brighty G, Plate L, Bare G, Chen W, Li S
J Am Chem Soc. 2017; 140(1):200-210.
PMID: 29265822
PMC: 5762408.
DOI: 10.1021/jacs.7b08366.
Chung B, White C, Yudin A
Nat Protoc. 2017; 12(6):1277-1287.
PMID: 28538738
DOI: 10.1038/nprot.2017.035.
Knight R, Gostev M, Ilisavskii S, Willis A, Melino G, Antonov A
Oncotarget. 2014; 5(3):659-66.
PMID: 24553133
PMC: 3996666.
DOI: 10.18632/oncotarget.1597.
Moore T, Mayne C, Katzenellenbogen J
Mol Endocrinol. 2009; 24(4):683-95.
PMID: 19933380
PMC: 2852352.
DOI: 10.1210/me.2009-0362.
Gallo D, Haddad I, Laurent G, Vinh J, Jacquemotte F, Jacquot Y
Nucl Recept Signal. 2008; 6:e007.
PMID: 18432312
PMC: 2329824.
DOI: 10.1621/nrs.06007.
Light activated recombination.
Link K, Shi Y, Koh J
J Am Chem Soc. 2005; 127(38):13088-9.
PMID: 16173704
PMC: 2512263.
DOI: 10.1021/ja0531226.
Stress facilitates classical conditioning in males, but impairs classical conditioning in females through activational effects of ovarian hormones.
Wood G, Shors T
Proc Natl Acad Sci U S A. 1998; 95(7):4066-71.
PMID: 9520494
PMC: 19964.
DOI: 10.1073/pnas.95.7.4066.
Changes in expression of transforming growth factor beta mRNA isoforms in patients undergoing tamoxifen therapy.
MacCallum J, Keen J, Bartlett J, Thompson A, Dixon J, Miller W
Br J Cancer. 1996; 74(3):474-8.
PMID: 8695368
PMC: 2074656.
DOI: 10.1038/bjc.1996.385.
Reactivation of apolipoprotein II gene transcription by cycloheximide reveals two steps in the deactivation of estrogen receptor-mediated transcription.
Sensel M, Binder R, Lazier C, Williams D
Mol Cell Biol. 1994; 14(3):1733-42.
PMID: 8114707
PMC: 358531.
DOI: 10.1128/mcb.14.3.1733-1742.1994.
Subunit structure of the nonactivated human estrogen receptor.
Segnitz B, Gehring U
Proc Natl Acad Sci U S A. 1995; 92(6):2179-83.
PMID: 7892243
PMC: 42447.
DOI: 10.1073/pnas.92.6.2179.
Interaction of tamoxifen with the multidrug resistance P-glycoprotein.
Callaghan R, Higgins C
Br J Cancer. 1995; 71(2):294-9.
PMID: 7841043
PMC: 2033580.
DOI: 10.1038/bjc.1995.59.
Functional estrogen receptors in a human preosteoclastic cell line.
Fiorelli G, Gori F, Petilli M, Tanini A, Benvenuti S, Serio M
Proc Natl Acad Sci U S A. 1995; 92(7):2672-6.
PMID: 7708703
PMC: 42280.
DOI: 10.1073/pnas.92.7.2672.
Antiestrogen action in breast cancer cells: modulation of proliferation and protein synthesis, and interaction with estrogen receptors and additional antiestrogen binding sites.
Katzenellenbogen B, Miller M, Mullick A, Sheen Y
Breast Cancer Res Treat. 1985; 5(3):231-43.
PMID: 4027393
DOI: 10.1007/BF01806018.
Oestradiol stimulates tyrosine phosphorylation and hormone binding activity of its own receptor in a cell-free system.
Auricchio F, Migliaccio A, Di Domenico M, Nola E
EMBO J. 1987; 6(10):2923-9.
PMID: 3691476
PMC: 553727.
DOI: 10.1002/j.1460-2075.1987.tb02596.x.
High efficiency covalent radiolabeling of the human androgen receptor. Studies in cultured fibroblasts using dihydrotestosterone 17 beta-bromoacetate.
Kovacs W, Turney M
J Clin Invest. 1988; 81(2):342-8.
PMID: 3339123
PMC: 329576.
DOI: 10.1172/JCI113326.
Covalent binding of the endogenous estrogen 16 alpha-hydroxyestrone to estradiol receptor in human breast cancer cells: characterization and intranuclear localization.
Swaneck G, Fishman J
Proc Natl Acad Sci U S A. 1988; 85(21):7831-5.
PMID: 3186693
PMC: 282290.
DOI: 10.1073/pnas.85.21.7831.
The development of tamoxifen for breast cancer therapy: a tribute to the late Arthur L. Walpole.
Jordan V
Breast Cancer Res Treat. 1988; 11(3):197-209.
PMID: 3048447
DOI: 10.1007/BF01807278.
Molecular cloning and characterization of rat estrogen receptor cDNA.
Koike S, Sakai M, Muramatsu M
Nucleic Acids Res. 1987; 15(6):2499-513.
PMID: 3031601
PMC: 340665.
DOI: 10.1093/nar/15.6.2499.
Estradiol receptor: phosphorylation on tyrosine in uterus and interaction with anti-phosphotyrosine antibody.
Migliaccio A, Rotondi A, Auricchio F
EMBO J. 1986; 5(11):2867-72.
PMID: 2431901
PMC: 1167236.
DOI: 10.1002/j.1460-2075.1986.tb04581.x.
65 and 47 kDa forms of estrogen receptor in human breast cancer: relation with estrogen responsiveness.
Jozan S, Julia A, Carretie A, Eche N, Maisongrosse V, Fouet B
Breast Cancer Res Treat. 1991; 19(2):103-9.
PMID: 1756269
DOI: 10.1007/BF01980940.
